JP2023543262A5 - - Google Patents
Info
- Publication number
- JP2023543262A5 JP2023543262A5 JP2023519180A JP2023519180A JP2023543262A5 JP 2023543262 A5 JP2023543262 A5 JP 2023543262A5 JP 2023519180 A JP2023519180 A JP 2023519180A JP 2023519180 A JP2023519180 A JP 2023519180A JP 2023543262 A5 JP2023543262 A5 JP 2023543262A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- polypeptide
- substitution
- canid
- constant domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063084241P | 2020-09-28 | 2020-09-28 | |
| US63/084,241 | 2020-09-28 | ||
| PCT/US2021/052338 WO2022067233A2 (en) | 2020-09-28 | 2021-09-28 | Canine antibody variants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543262A JP2023543262A (ja) | 2023-10-13 |
| JP2023543262A5 true JP2023543262A5 (enExample) | 2024-09-27 |
Family
ID=78599123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519180A Pending JP2023543262A (ja) | 2020-09-28 | 2021-09-28 | イヌ科動物抗体バリアント |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US12612454B2 (enExample) |
| EP (1) | EP4217384A2 (enExample) |
| JP (1) | JP2023543262A (enExample) |
| KR (1) | KR20230079148A (enExample) |
| CN (1) | CN116438196A (enExample) |
| AR (1) | AR123636A1 (enExample) |
| AU (1) | AU2021349301A1 (enExample) |
| BR (1) | BR112023005393A2 (enExample) |
| CA (1) | CA3194936A1 (enExample) |
| CL (2) | CL2023000878A1 (enExample) |
| CO (1) | CO2023004102A2 (enExample) |
| EC (1) | ECSP23030271A (enExample) |
| IL (1) | IL301413A (enExample) |
| MX (1) | MX2023003624A (enExample) |
| PE (1) | PE20231374A1 (enExample) |
| TW (1) | TW202229337A (enExample) |
| WO (1) | WO2022067233A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115996949A (zh) * | 2020-04-17 | 2023-04-21 | 硕腾服务有限责任公司 | 犬抗体变异体 |
| MX2023003624A (es) | 2020-09-28 | 2023-04-11 | Zoetis Services Llc | Variantes de anticuerpos caninos. |
| AU2023289332A1 (en) * | 2022-06-21 | 2024-12-12 | Zoetis Services Llc | Canine antibody mutants |
| JP2026508096A (ja) | 2023-01-20 | 2026-03-10 | ゾエティス・サービシーズ・ユーケー・リミテッド | 治療抗体 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5698762A (en) | 1994-12-09 | 1997-12-16 | Dauerman; Leonard | Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons |
| US20030031671A1 (en) | 2001-08-01 | 2003-02-13 | Sydney Welt | Methods of treating colon cancer utilizing tumor-specific antibodies |
| AU2005285347A1 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| AU2005304624B2 (en) | 2004-11-12 | 2010-10-07 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| WO2012024650A2 (en) | 2010-08-19 | 2012-02-23 | Abbott Laboratories | Anti-ngf antibodies and their use |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| CA2875783C (en) | 2012-06-06 | 2018-12-11 | Zoetis Llc | Caninized anti-ngf antibodies and methods thereof |
| CN106029697B (zh) | 2013-12-20 | 2021-06-04 | 英特维特国际股份有限公司 | 具有经修饰的ch2-ch3序列的犬抗体 |
| US20210388053A1 (en) * | 2018-10-18 | 2021-12-16 | Kindred Biosciences, Inc. | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use |
| EP3887397A1 (en) * | 2018-11-28 | 2021-10-06 | Bristol-Myers Squibb Company | Antibodies comprising modified heavy constant regions |
| JP7536294B2 (ja) * | 2018-12-05 | 2024-08-20 | 株式会社バイカ・セラピュティクス | 抗体のＦｃ領域改変体 |
| CN113544153B (zh) | 2019-01-03 | 2024-12-10 | 因外泰克斯公司 | 用于增加治疗剂在犬中的半衰期的组合物及使用方法 |
| CN115996949A (zh) | 2020-04-17 | 2023-04-21 | 硕腾服务有限责任公司 | 犬抗体变异体 |
| US20220119513A1 (en) | 2020-06-08 | 2022-04-21 | Zoetis Services Llc | Anti-tgfb antibodies and therapeutic uses thereof |
| MX2023003624A (es) | 2020-09-28 | 2023-04-11 | Zoetis Services Llc | Variantes de anticuerpos caninos. |
-
2021
- 2021-09-28 MX MX2023003624A patent/MX2023003624A/es unknown
- 2021-09-28 EP EP21806440.0A patent/EP4217384A2/en active Pending
- 2021-09-28 CA CA3194936A patent/CA3194936A1/en active Pending
- 2021-09-28 IL IL301413A patent/IL301413A/en unknown
- 2021-09-28 AR ARP210102697A patent/AR123636A1/es unknown
- 2021-09-28 BR BR112023005393A patent/BR112023005393A2/pt unknown
- 2021-09-28 TW TW110136032A patent/TW202229337A/zh unknown
- 2021-09-28 KR KR1020237014355A patent/KR20230079148A/ko active Pending
- 2021-09-28 JP JP2023519180A patent/JP2023543262A/ja active Pending
- 2021-09-28 CN CN202180065886.6A patent/CN116438196A/zh active Pending
- 2021-09-28 AU AU2021349301A patent/AU2021349301A1/en active Pending
- 2021-09-28 US US18/246,716 patent/US12612454B2/en active Active
- 2021-09-28 PE PE2023001231A patent/PE20231374A1/es unknown
- 2021-09-28 WO PCT/US2021/052338 patent/WO2022067233A2/en not_active Ceased
-
2023
- 2023-03-27 CL CL2023000878A patent/CL2023000878A1/es unknown
- 2023-03-29 CO CONC2023/0004102A patent/CO2023004102A2/es unknown
- 2023-04-25 EC ECSENADI202330271A patent/ECSP23030271A/es unknown
-
2024
- 2024-02-29 CL CL2024000628A patent/CL2024000628A1/es unknown